Rev-erbβ Activators

The first class of Rev-erbβ activators are those that alter kinase activity, such as lithium, rapamycin, quercetin, and LY294002. These compounds target kinases like GSK3β, mTOR, and PI3K, which have direct or indirect interactions with Rev-erbβ. Inhibition of these kinases can result in the enhancement of Rev-erbβ function. For instance, lithium inhibits GSK3β, a kinase that phosphorylates Rev-erbβ, thereby indirectly enhancing its functional activity.

The second class of Rev-erbβ activators are those that modulate cellular stress response and energy sensing pathways, such as resveratrol, forskolin, metformin, sulforaphane, SRT1720, AICAR, berberine, and N-acetylcysteine. These compounds can activate cellular pathways like Sirt1, AMPK, and Nrf2, or increase cAMP levels, which are known to affect the function of Rev-erbβ. For instance, resveratrol activates Sirt1, which deacetylates and activates Rev-erbβ, thus enhancing its function. Similarly, metformin and AICAR, as AMPK activators, can enhance the functional activity of Rev-erbβ, as AMPK activation has been linked to an increase in its functional activity.